The Journal of Immunology, Vol 152, Issue 5 2344-2350, Copyright © 1994 by American Association of Immunologists

ARTICLES

CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans

JO Hill and KM Aguirre
Trudeau Institute, Inc., Saranac Lake, NY 12983.

In immunodeficient hosts, a failure in defense mechanisms allows Cryptococcus neoformans to establish foci of infection in the brain. Immune and nonspecific responses in the primary site of infection in the lung have been described, but those extrapulmonary defense mechanisms that can be mobilized against the yeast have received little attention. This paper describes a response expressed against yeast in the brain of immunocompetent hosts, a response that is weakened in hosts deficient in CD4+ T cells. When a small number of yeast gain access to the vasculature, for example through an i.v. injection, about 0.1% establish themselves in the brain. Normal mice but not SCID mice have the capacity to suppress the multiplication of these yeast cells. The host response is accelerated in mice that are recovering from a primary lung infection, resulting in long term survival without antibiotic chemotherapy. This response is ablated by anti-CD4 mAb treatment and CD4+ cells obtained from infected primed donors are needed to confer immunity on SCID recipients. The critical target for the anti-Cryptococcus immune response are yeast in the brain cortex. However, rather than preventing the colonization of the brain by blood- borne yeast, immunity apparently serves to restrict the growth of yeast in a small number of established foci.

This article has been cited by other articles:

				S. Arora, R. A. McDonald, G. B. Toews, and G. B. Huffnagle Effect of a CD4-Depleting Antibody on the Development of Cryptococcus neoformans-Induced Allergic Bronchopulmonary Mycosis in Mice Infect. Immun., July 1, 2006; 74(7): 4339 - 4348. [Abstract] [Full Text] [PDF]

				R. B. Rock, G. Gekker, S. Hu, W. S. Sheng, M. Cheeran, J. R. Lokensgard, and P. K. Peterson Role of Microglia in Central Nervous System Infections Clin. Microbiol. Rev., October 1, 2004; 17(4): 942 - 964. [Abstract] [Full Text] [PDF]

				C. Biondo, C. Beninati, M. Bombaci, L. Messina, G. Mancuso, A. Midiri, R. Galbo, and G. Teti Induction of T Helper Type 1 Responses by a Polysaccharide Deacetylase from Cryptococcus neoformans Infect. Immun., September 1, 2003; 71(9): 5412 - 5417. [Abstract] [Full Text] [PDF]

				G. M. Almeida, R. M. Andrade, and C. A. M. Bento The Capsular Polysaccharides of Cryptococcus neoformans Activate Normal CD4+ T Cells in a Dominant Th2 Pattern J. Immunol., November 15, 2001; 167(10): 5845 - 5851. [Abstract] [Full Text] [PDF]

				D. O. Beenhouwer, S. Shapiro, M. Feldmesser, A. Casadevall, and M. D. Scharff Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans Infect. Immun., October 1, 2001; 69(10): 6445 - 6455. [Abstract] [Full Text] [PDF]

				K. L. Buchanan and H. A. Doyle Requirement for CD4+ T Lymphocytes in Host Resistance against Cryptococcus neoformans in the Central Nervous System of Immunized Mice Infect. Immun., February 1, 2000; 68(2): 456 - 462. [Abstract] [Full Text] [PDF]

				H. A. Doyle and J. W. Murphy Role of the C-C Chemokine, TCA3, in the Protective Anticryptococcal Cell-Mediated Immune Response J. Immunol., April 15, 1999; 162(8): 4824 - 4833. [Abstract] [Full Text] [PDF]

				C. H. Mody, C. J. Wood, R. M. Syme, and J. C. L. Spurrell The Cell Wall and Membrane of Cryptococcus neoformans Possess a Mitogen for Human T Lymphocytes Infect. Immun., February 1, 1999; 67(2): 936 - 941. [Abstract] [Full Text] [PDF]

				K. Decken, G. Kohler, K. Palmer-Lehmann, A. Wunderlin, F. Mattner, J. Magram, M. K. Gately, and G. Alber Interleukin-12 Is Essential for a Protective Th1 Response in Mice Infected with Cryptococcus neoformans Infect. Immun., October 1, 1998; 66(10): 4994 - 5000. [Abstract] [Full Text] [PDF]

				K. M. Aguirre, G. W. Gibson, and L. L. Johnson Decreased Resistance to Primary Intravenous Cryptococcus neoformans Infection in Aged Mice despite Adequate Resistance to Intravenous Rechallenge Infect. Immun., September 1, 1998; 66(9): 4018 - 4024. [Abstract] [Full Text] [PDF]

				M. M. Lipovsky, A. E. Juliana, G. Gekker, S. Hu, A. I. M. Hoepelman, and P. K. Peterson Clin. Vaccine Immunol., May 1, 1998; 5(3): 410 - 411. [Abstract]

				K. A. Hoag, M. F. Lipscomb, A. A. Izzo, and N. E. Street IL-12 and IFN-gamma Are Required for Initiating the Protective Th1 Response to Pulmonary Cryptococcosis in Resistant C.B-17 Mice Am. J. Respir. Cell Mol. Biol., December 1, 1997; 17(6): 733 - 739. [Abstract] [Full Text]

				R. Yuan, A. Casadevall, J. Oh, and M. D. Scharff T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice PNAS, March 18, 1997; 94(6): 2483 - 2488. [Abstract] [Full Text] [PDF]